1. Home
  2. NOTV vs SRL Comparison

NOTV vs SRL Comparison

Compare NOTV & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • SRL
  • Stock Information
  • Founded
  • NOTV 1974
  • SRL 2017
  • Country
  • NOTV United States
  • SRL China
  • Employees
  • NOTV N/A
  • SRL N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • SRL Professional Services
  • Sector
  • NOTV Health Care
  • SRL Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • SRL Nasdaq
  • Market Cap
  • NOTV 126.3M
  • SRL 122.8M
  • IPO Year
  • NOTV 1997
  • SRL N/A
  • Fundamental
  • Price
  • NOTV $4.27
  • SRL $8.02
  • Analyst Decision
  • NOTV Strong Buy
  • SRL
  • Analyst Count
  • NOTV 3
  • SRL 0
  • Target Price
  • NOTV $5.92
  • SRL N/A
  • AVG Volume (30 Days)
  • NOTV 1.2M
  • SRL 19.1K
  • Earning Date
  • NOTV 02-05-2025
  • SRL 12-31-2024
  • Dividend Yield
  • NOTV N/A
  • SRL N/A
  • EPS Growth
  • NOTV N/A
  • SRL N/A
  • EPS
  • NOTV N/A
  • SRL N/A
  • Revenue
  • NOTV $490,739,000.00
  • SRL $33,997,735.00
  • Revenue This Year
  • NOTV $7.14
  • SRL N/A
  • Revenue Next Year
  • NOTV $5.73
  • SRL N/A
  • P/E Ratio
  • NOTV N/A
  • SRL N/A
  • Revenue Growth
  • NOTV N/A
  • SRL N/A
  • 52 Week Low
  • NOTV $1.23
  • SRL $5.74
  • 52 Week High
  • NOTV $11.42
  • SRL $9.99
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 49.19
  • SRL 53.27
  • Support Level
  • NOTV $3.87
  • SRL $7.93
  • Resistance Level
  • NOTV $4.67
  • SRL $8.39
  • Average True Range (ATR)
  • NOTV 0.54
  • SRL 0.65
  • MACD
  • NOTV -0.10
  • SRL 0.04
  • Stochastic Oscillator
  • NOTV 22.22
  • SRL 46.76

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

Share on Social Networks: